IP Verse

Biontech Rna Pharmaceuticals Gmbh opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Biontech Rna Pharmaceuticals Gmbh

Patent Number:
EP3319622
Title:
Method For Producing Rna Molecule Compositions
Applicant:
CUREVAC AG
Opposition Date:
Nov 12, 2020
Patent Number:
EP3173092
Title:
Rna Containing Composition For Treatment Of Tumor Diseases
Applicant:
CUREVAC AG
Opposition Date:
Mar 26, 2020

Latest patents of Biontech Rna Pharmaceuticals Gmbh opposed by its competitors

Patent:
EP3445850
Grant Date:
Oct 27, 2021
Title:
Methods For Providing Single-Stranded Rna
Oppositions:
1
Patent:
EP3473267
Grant Date:
Sep 8, 2021
Title:
Individualized Vaccines For Cancer
Oppositions:
1
Patent:
EP2714071
Grant Date:
Jul 10, 2019
Title:
Individualized Vaccines For Cancer
Oppositions:
3

Competitors of Biontech Rna Pharmaceuticals Gmbh

CUREVAC AG

WITHERS & ROGERS LLP

CUREVAC SE

Want to track Biontech Rna Pharmaceuticals Gmbh?

Feel free to send us a message here and we will get back to you